APPLICATION OF ANTIPLATELET AND ANGIOPROTECTIVE THERAPY IN PATIENTS WITH PLACENTAL INSUFFICIENCY DEVELOPMENT RISK FACTORS

The article describes the basic principles of correction and prevention of subclinical forms of placental insufficiency in patients with anamnestic  risk factors for the development of this pathology. Pathogenetic substantiation of administration of antiplatelet and angioprotective therapy during pr...

Full description

Bibliographic Details
Main Author: A. V. Vorobiev
Format: Article
Language:Russian
Published: Remedium Group LLC 2016-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/1433
_version_ 1827961650318147584
author A. V. Vorobiev
author_facet A. V. Vorobiev
author_sort A. V. Vorobiev
collection DOAJ
description The article describes the basic principles of correction and prevention of subclinical forms of placental insufficiency in patients with anamnestic  risk factors for the development of this pathology. Pathogenetic substantiation of administration of antiplatelet and angioprotective therapy during pregnancy in risk group patients is provided. It is given to discuss the possibilities of early detection of risk factors and prevention of clinical manifestations.
first_indexed 2024-04-09T16:30:01Z
format Article
id doaj.art-c641643d44394d1f804bfc1c3f50d170
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:30:01Z
publishDate 2016-12-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-c641643d44394d1f804bfc1c3f50d1702023-04-23T06:57:10ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902016-12-01012505510.21518/2079-701X-2016-12-55-551429APPLICATION OF ANTIPLATELET AND ANGIOPROTECTIVE THERAPY IN PATIENTS WITH PLACENTAL INSUFFICIENCY DEVELOPMENT RISK FACTORSA. V. Vorobiev0Sechenov First Moscow State Medical University, MoscowThe article describes the basic principles of correction and prevention of subclinical forms of placental insufficiency in patients with anamnestic  risk factors for the development of this pathology. Pathogenetic substantiation of administration of antiplatelet and angioprotective therapy during pregnancy in risk group patients is provided. It is given to discuss the possibilities of early detection of risk factors and prevention of clinical manifestations.https://www.med-sovet.pro/jour/article/view/1433placental insufficiencyantiplatelet drugsdipiridamolhypercoagulationprevention of thrombotic complications
spellingShingle A. V. Vorobiev
APPLICATION OF ANTIPLATELET AND ANGIOPROTECTIVE THERAPY IN PATIENTS WITH PLACENTAL INSUFFICIENCY DEVELOPMENT RISK FACTORS
Медицинский совет
placental insufficiency
antiplatelet drugs
dipiridamol
hypercoagulation
prevention of thrombotic complications
title APPLICATION OF ANTIPLATELET AND ANGIOPROTECTIVE THERAPY IN PATIENTS WITH PLACENTAL INSUFFICIENCY DEVELOPMENT RISK FACTORS
title_full APPLICATION OF ANTIPLATELET AND ANGIOPROTECTIVE THERAPY IN PATIENTS WITH PLACENTAL INSUFFICIENCY DEVELOPMENT RISK FACTORS
title_fullStr APPLICATION OF ANTIPLATELET AND ANGIOPROTECTIVE THERAPY IN PATIENTS WITH PLACENTAL INSUFFICIENCY DEVELOPMENT RISK FACTORS
title_full_unstemmed APPLICATION OF ANTIPLATELET AND ANGIOPROTECTIVE THERAPY IN PATIENTS WITH PLACENTAL INSUFFICIENCY DEVELOPMENT RISK FACTORS
title_short APPLICATION OF ANTIPLATELET AND ANGIOPROTECTIVE THERAPY IN PATIENTS WITH PLACENTAL INSUFFICIENCY DEVELOPMENT RISK FACTORS
title_sort application of antiplatelet and angioprotective therapy in patients with placental insufficiency development risk factors
topic placental insufficiency
antiplatelet drugs
dipiridamol
hypercoagulation
prevention of thrombotic complications
url https://www.med-sovet.pro/jour/article/view/1433
work_keys_str_mv AT avvorobiev applicationofantiplateletandangioprotectivetherapyinpatientswithplacentalinsufficiencydevelopmentriskfactors